The grant funding will be used to demonstrate the value of NCPDP standards in providing consumers with transparency and choice on prescription medications, while also providing payment assistance and discount options to lower out-of-pocket costs and improve medication adherence and outcomes.

SCOTTSDALE, Ariz., Dec. 18, 2023 /PRNewswire-PRWeb/ — The NCPDP Foundation Board of Trustees has awarded a grant to RxEOB.Com, LLC (“RxEOB”), to fund an innovative project that will use NCPDP’s real-time standards to make it easy and convenient for consumers to view medication options, alternatives and cost information, as well as payment assistance options and the ability to select their preferred medication and pharmacy before a prescription is filled. This is the NCPDP Foundation’s first grant funding a project that uses the same NCPDP industry standards available to prescribers, pharmacists, and other healthcare industry participants, to bring consumers transparency and choice on prescription medications. The new, consumer-facing use of NCPDP’s industry standards can help improve medication adherence and outcomes, patient safety, and enhance efficiencies to improve the healthcare experience for patients, pharmacists, and prescribers.

The grant supports all three of the NCPDP Foundation’s strategic initiatives: increasing patient access to care; increasing the role and value of pharmacists; and enhancing patient safety. It also aligns with the NCPDP Foundation’s Vision of a healthcare ecosystem that continuously innovates and fully incorporates health information technology (HIT) to deliver better outcomes for the common good of all.

The grant project will use NCPDP’s SCRIPT Standard for ePrescribing and its Real-Time Prescription Benefit Standard to provide consumers information on their out-of-pocket costs for medications. Specific NCPDP SCRIPT transactions used in the project include CancelRx and RxChange. Both transactions fortify patient safety and simplify workflows for pharmacists and prescribers, offering an automated and efficient means for pharmacists and prescribers to collaborate on adjusting and discontinuing medication therapies.

Under the grant project, patients in the study will use RxEOB’s RxWallet® app to view medication information and out-of-pocket costs prior to dispensing. Patients will also have access to available payment strategies such as discount card services, and coupons, as well as compendia information on label warnings, overdose information and more, to streamline access to comprehensive medication information. The patient can then select a pharmacy provider with full knowledge of their out-of-pocket costs, which supports medication adherence and ultimately, health outcomes. While this grant project uses RxWallet, the patient engagement strategy using NCPDP’s SCRIPT and Real-Time Prescription Benefit Standards can be used by others in the industry. The project, which can benefit consumers, pharmacists, prescribers and payers, has specific aims for lowering patients’ out-pocket costs, drug spend for benefit sponsors, and prescription abandonment rates.

“We are excited to see the outcomes of this grant, extending the powerful capabilities of the NCPDP SCRIPT and Real-Time Prescription Benefit Standards to the consumer,” explained J.W. Hill, MBAHCM, CNED, Executive Director, NCPDP Foundation. “While prescribers can use the Real-Time Prescription Benefit Standard at the point of care to discuss medication options with patients, gaps in care still remain, making the consumer-pharmacist relationship an important and trusted option to ensure patients don’t abandon medication therapy altogether due to costs.”

Hill continued, “Using NCPDP Standards to support consumer transparency and choice meets the expectations of engaged patients and caregivers who are proactive in managing their health. It also relieves pharmacists and prescribers of unnecessary work so they can focus their time on clinical care, optimizing their expertise and training.”

“This implementation of the RxWallet® application provides RxEOB and the NCPDP Foundation a wonderful opportunity to demonstrate an untapped use of NCPDP’s standards in action, improving patients’ access to care by working collaboratively with their health plan, doctor and pharmacy” said Robert Oscar, CEO of RxEOB. “We appreciate the work that the NCPDP Foundation is doing to put the power of the industry in the patient’s hands.”

The NCPDP Foundation grant to RxEOB.Com, LLC, was made possible in part by the Foundation’s $1 Million Endowment in honor of NCPDP Founder, Benjamin D. Ward, and The Mary and Charles D. Pulido Endowment Fund as granted to the NCPDP Foundation by the NCPDP Board of Trustees.

About NCPDP Foundation
The NCPDP Foundation is a 501(c)(3) nonprofit charitable organization headquartered in Scottsdale, Arizona and is affiliated with the National Council for Prescription Drug Programs (NCPDP). The NCPDP Foundation was established in December 2012 to support research, education, and charitable involvement within the healthcare industry. For more information, visit http://ncpdpfoundation.org.

About RxEOB
RxEOB.com, LLC is a digital patient engagement company grounded in 20 years of health information technology, serving some of the nation’s largest health insurance providers based in Richmond, VA. RxEOB believes patients, families, employers, and health plans make the best decisions about health and cost when they are informed; and provides applications and tools to help sponsors manage their prescription benefits to reduce overall drug spend. RxWallet is the revolutionary new application designed to assist consumers to achieve the same goal. For additional information visit RxWallet.com.

Media Contact

Janet Cabibbo, NCPDP Foundation, 4804771000 x 104, [email protected], www.NCPDPFoundation.org 

Maggie Bruce, NCPDP Foundation, 4804771000 x 144, [email protected], www.NCPDPFoundation.org 

Twitter

SOURCE NCPDP Foundation

SightMD Connecticut, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Kimberly Ann Lucey M.D. Through this strategic partnership Dr. Lucey’s practice at 1699 King Street, Suite 102 in Enfield, CT, will expand SightMD Connecticut’s presence.

HAUPPAUGE, N.Y., Dec. 18, 2023 /PRNewswire-PRWeb/ — SightMD Connecticut, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Kimberly Ann Lucey M.D. Through this strategic partnership Dr. Lucey’s practice at 1699 King Street, Suite 102 in Enfield, CT, will expand SightMD Connecticut’s presence.

Kimberly Ann Lucey, M.D. graduated Magna Cum Laude from Fairfield University with a major in chemistry and a minor in both mathematics and biology. She then obtained her medical degree from Georgetown University School of Medicine in Washington, D.C. She completed her ophthalmic residency at Sinai Hospital of Baltimore in conjunction with The Johns Hopkins Wilmer Eye Institute Hospital. Dr. Lucey served as Chief Resident in her final year.

Dr. Lucey relocated to Connecticut and opened her own practice in 1996 where she practices general ophthalmology with a particular interest in advanced cataract surgery offering astigmatism correcting and multifocal intraocular lens implants and the medical management of glaucoma. She is a Diplomat of the American Board of Ophthalmology and an active member of the Hartford County Medical Association, the Connecticut Society of Eye Physicians, the Connecticut State Medical Society, and the American Academy of Ophthalmology. Dr. Lucey prides herself on delivering quality care to informed patients in a comfortable and convenient setting. When asked about how she feels about joining SightMD Connecticut Dr. Lucey said “I am pleased to partner with a company that shares my goal of patient centric care. This is a distinguishing feature of SightMD and the main reason that I chose to align with them.”

Jonathan Lujan, CEO of Sight Growth Partners added “Sight Growth Partners is privileged to welcome Dr. Lucey into SightMD Connecticut where all of the doctors and staff provide the highest quality of eye care to their patients.”

Dr. Lucey will continue to care for her patients at her Enfield, CT office. With this partnership her patients and the community will have access to seamless care at all of SightMD’s Connecticut practice locations.

Dr. Lucey was advised by BSM Consulting on this transaction.

About SightMD Connecticut
SightMD Connecticut offers patients access to 7 eye care doctors through the convenience of 5 clinical locations and 1 Ambulatory Surgery Center in Connecticut. Its services include general eye exams, cataract surgery, LASIK and refractive eye surgery, macular degeneration, pediatric eye care, diabetic eye disease, glaucoma care, and dry eye management. Sight Growth Partners is the administrative services provider for SightMD Connecticut, as well as SightMD Pennsylvania, SightMD New Jersey and SightMD in New York. For more information about SightMD Connecticut, please visit https://www.sightmd.com/sightmd-ct/

About Sight Growth Partners
Sight Growth Partners is the leading administrative services provider for the ophthalmology sector including SightMD in New York, SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. It has over 140 employees who provide administrative solutions to physicians, ophthalmology clinics and ambulatory surgery centers. Sight Growth Partners provides its clients with world-class administrative services, including a 24/7 call center, billing, credentialing, marketing, human resources, and other services, enabling them to continue delivering best-in-class care to patients in their communities. Sight Growth Partners is backed by Chicago Pacific Founders, a leading middle market private equity firm which focuses exclusively on partnerships with growing companies in the healthcare services sector. For more information about Sight Growth Partners, please visit http://www.sightgrowthpartners.com. 

Media Contact

Stephanie Penza, SightGrowthPartners, 6318352613, [email protected], www.sightmd.com

SOURCE SightMD